1. A 24‐week study to evaluate the efficacy and safety of once‐weekly dulaglutide added on to glimepiride in type 2 diabetes (AWARD‐8). Issue 5 (19th February 2016) Authors: Dungan, K. M.; Weitgasser, R.; Perez Manghi, F.; Pintilei, E.; Fahrbach, J. L.; Jiang, H. H.; Shell, J.; Robertson, K. E. Journal: Diabetes, obesity & metabolism Issue: Volume 18:Issue 5(2016) Page Start: 475 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗